Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Teis

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nature Communications|February 4, 2026
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptorChiou-Tsun Tsai, Jorge Ibanez-Vega, Pan Yin, et al.
Journal for Immunotherapy of Cancer|March 30, 2026
RASA2 deletion rescues immune synapse dysfunction, enhancing CAR T cell efficacy against DMGsJorge Ibanez-Vega, Robert Teis, Jennifer K Ocasio, et al.
Neoplasia (New York, N.Y.)|August 30, 2023
Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline gliomaMonika Sharma, Ivana Barravecchia, Brian Magnuson, et al.
Brain, Behavior, and Immunity|March 27, 2022
Early life adversity drives sex-specific anhedonia and meningeal immune gene expression through mast cell activationNatalia Duque-Wilckens, Robert Teis, Erika Sarno, et al.
Molecular Cancer Therapeutics|September 18, 2023
Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor RecurrenceMonika Sharma, Ivana Barravecchia, Robert Teis, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Glucose-dependent glycosphingolipid biosynthesis fuels CD8<sup>+</sup> T cell function and tumor controlJoseph Longo, Lisa M DeCamp, Brandon M Oswald, et al.
Cell Metabolism|August 6, 2025
Glucose-dependent glycosphingolipid biosynthesis fuels CD8<sup>+</sup> T cell function and tumor controlJoseph Longo, Lisa M DeCamp, Brandon M Oswald, et al.
Immunity|July 29, 2023
Ketolysis drives CD8<sup>+</sup> T cell effector function through effects on histone acetylationKatarzyna M Luda, Joseph Longo, Susan M Kitchen-Goosen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nature Communications|February 4, 2026
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptorChiou-Tsun Tsai, Jorge Ibanez-Vega, Pan Yin, et al.
Journal for Immunotherapy of Cancer|March 30, 2026
RASA2 deletion rescues immune synapse dysfunction, enhancing CAR T cell efficacy against DMGsJorge Ibanez-Vega, Robert Teis, Jennifer K Ocasio, et al.
Neoplasia (New York, N.Y.)|August 30, 2023
Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline gliomaMonika Sharma, Ivana Barravecchia, Brian Magnuson, et al.
Brain, Behavior, and Immunity|March 27, 2022
Early life adversity drives sex-specific anhedonia and meningeal immune gene expression through mast cell activationNatalia Duque-Wilckens, Robert Teis, Erika Sarno, et al.
Molecular Cancer Therapeutics|September 18, 2023
Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor RecurrenceMonika Sharma, Ivana Barravecchia, Robert Teis, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Glucose-dependent glycosphingolipid biosynthesis fuels CD8<sup>+</sup> T cell function and tumor controlJoseph Longo, Lisa M DeCamp, Brandon M Oswald, et al.
Cell Metabolism|August 6, 2025
Glucose-dependent glycosphingolipid biosynthesis fuels CD8<sup>+</sup> T cell function and tumor controlJoseph Longo, Lisa M DeCamp, Brandon M Oswald, et al.
Immunity|July 29, 2023
Ketolysis drives CD8<sup>+</sup> T cell effector function through effects on histone acetylationKatarzyna M Luda, Joseph Longo, Susan M Kitchen-Goosen, et al.
Pageof 1